Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury

Spinal Cord Injuries Clinical Trial

— VRWalk  

Official title:

A Multisite Randomized Clinical Trial to Examine the Efficacy and Mechanisms of Immersive Virtual Walking Treatment for Neuropathic Pain in Spinal Cord Injury

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05005026
• Other study ID #: HM20020719
• Secondary ID: W81XWH-20-1-0775
• Status: Recruiting
• Phase: N/A
• Start date: November 23, 2021
• Est. completion date: September 2026

Study information

• Verified date: August 2023
• Source: Virginia Commonwealth University
• Contact: Hannah Palanchi
• Phone: 804-569-5965
• Email: hannah.palanchi[@]vcuhealth.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with chronic spinal cord injury.

Description:

Many people with SCI experience neuropathic pain. Neuropathic pain is often described as sharp, burning, or electric. 'Traditional' treatments often do not do a good job at reducing neuropathic pain. Therefore, it is important to see if 'non-traditional' treatments might work. Scientists think that neuropathic pain occurs in SCI because the sensations coming from the eyes and up the spinal cord to the brain do not match what the brain thinks it told the body to do. This 'mis-match' may result in changes in the brain that make neuropathic pain possible. Virtual reality walking reduces this 'mis-match.' It does this by creating the 'illusion' that the person is walking. The brain then thinks it is telling the body to walk AND the information coming from the eyes matches its instructions. This 'matching' may reverse the brain changes that made neuropathic pain possible.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 250
• Est. completion date: September 2026
• Est. primary completion date: September 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• The study will recruit individuals with complete and incomplete injury (American Spinal Injury Association [ASIA] classification A, B, C, D) with lumbar, paraplegic,

or low tetraplegic (C5-C7) injury. Additional criterial will include:

1. persistent NP symptoms that are of daily severity of at least 4/10 for 3 or more months

2. endorsement of more than 2 items on a 7-item Spinal Cord Injury Pain Instrument, SCIPI

3. age of 18 or older

4. more than one-year post-injury

5. neuropathic pain during the last 7 days

6. ability to move elbows against gravity

7. must have mobile connectivity with usable service)

8. SCIPI and DN4 scores for neuropathic pain must be 2 or more

9. must be stable on pain medication for 1 or more months

10. must be cleared on the VRWalk physical activity clearance scale

Exclusion Criteria:

1. Not meeting injury type criteria

2. Not meeting NP criteria

3. Age 17 or less

4. Less than a year following injury

5. Inability to comprehend spoken English

6. Prisoners

7. must not have motion sickness that interferes with daily life

8. blind

Related Conditions & MeSH terms

• Neuralgia
• Neuropathic Pain
• Spinal Cord Injuries
• Wounds and Injuries

Intervention

Other:
• VR Game 1
Individuals playing VR game 1 will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart.
• VR Game 2
Individuals playing VR game 2 will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart.

Locations

Country	Name	City	State
Australia	University of New South Wales	Sydney	New South Wales
United States	University of Alabama at Birmingham	Birmingham	Alabama
United States	Virginia Commonwealth University	Richmond	Virginia

Sponsors (4)

Lead Sponsor	Collaborator
Virginia Commonwealth University	Immersive Experience Labs, McGuire Veterans Hospital, United States Department of Defense

Countries where clinical trial is conducted

United States,  Australia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Pain Intensity	The Numeric Rating Scale (NRS) measures pain intensity via 0-10 numeric rating scale 0-10 where 0 is no pain and 10 is the worst pain imaginable.	Baseline - final follow up (up to 18 months)
Secondary	Change in Pain Quality	The Neuropathic Pain Scale (NPS) assesses the distinct pain qualities including sharpness, heat/cold, dullness, intensity, overall unpleasantness, and surface vs. deep pain. The NPS consists of 10 items. All the items are rated 0-10 scale, with higher score indicative of more neuropathic pain for each type of respective pain.	Baseline - final follow up (up to 18 months)
Secondary	Change in Pain Interference	The International Spinal Cord Injury Pain Basic Data Set version 2.0 interference assesses the degree to which pain interferes with day-to-day activities, mood, and sleep. Items are scored on a 0-10 numeric rating scale and scores are summed to yield an interference score ranging from 0 to 30. Higher scores indicate greater interference from pain.	Baseline - final follow up (up to 18 months)
Secondary	Post treatment change	The Patient Global Impression of Change is a one item 7 point Likert item assessing improvement of the participants overall status. Higher scores indicate less perceived improvement.; Range of scores: 1-7	at follow up (up to 18 months)
Secondary	Change in mood	Mood will be assessed using the Patient Health Questionnaire-9. Participants will be asked to rate have how often they have been bothered by specific problems on a 4-point Likert scale. The items are summed to yield a score ranging from 0-27. Higher scores indicate worse mood.	Baseline - final follow up (up to 18 months)
Secondary	Change in quality of life	Quality of life is assessed by the Satisfaction with Life Scale. This is a 5 item survey. Response options are a 7-point Likert scale. Items may be assessed individually or by summing items.; Range of scores: 5-35. Higher scores indicate more satisfaction in life	Baseline - final follow up (up to 18 months)
Secondary	Neurological changes	Functional Magnetic Resonance Imaging (fMRI) will be used to observe neurological changes. Pre and post study images will be compared by experienced researchers.	Baseline - 6 months